Gossamer Bio’s latest analyst update comes with no change to the existing price target, which keeps the current valuation view firmly in place for now. With no fresh analyst commentary accompanying this update, the lack of a price target move itself becomes the key signal for you to interpret. Read on to see how to track these kinds of quiet shifts in the story and what to watch to stay on top of the evolving narrative around the stock. Analyst Price Targets don't always capture the full...